PDT Partners’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,163
| Closed | -$130K | – | 847 |
|
|
2024
Q3 | $130K | Sell |
22,163
-53,542
| -71% | -$313K | 0.01% | 685 |
|
|
2024
Q2 | $599K | Buy |
+75,705
| New | +$599K | 0.06% | 431 |
|
|
2022
Q3 | – | Sell |
-10,165
| Closed | -$60K | – | 1112 |
|
|
2022
Q2 | $60K | Buy |
+10,165
| New | +$60K | 0.01% | 910 |
|
|
2022
Q1 | – | Sell |
-27,100
| Closed | -$73K | – | 1139 |
|
|
2021
Q4 | $73K | Hold |
27,100
| – | – | 0.01% | 838 |
|
|
2021
Q3 | $71K | Sell |
27,100
-9,700
| -26% | -$25.4K | 0.01% | 744 |
|
|
2021
Q2 | $152K | Sell |
36,800
-52,358
| -59% | -$216K | 0.01% | 738 |
|
|
2021
Q1 | $420K | Buy |
89,158
+33,841
| +61% | +$159K | 0.03% | 538 |
|
|
2020
Q4 | $396K | Buy |
55,317
+10,465
| +23% | +$74.9K | 0.03% | 493 |
|
|
2020
Q3 | $479K | Buy |
44,852
+9,686
| +28% | +$103K | 0.03% | 455 |
|
|
2020
Q2 | $444K | Buy |
+35,166
| New | +$444K | 0.03% | 441 |
|
|
2020
Q1 | – | Sell |
-10,078
| Closed | -$141K | – | 872 |
|
|
2019
Q4 | $141K | Buy |
+10,078
| New | +$141K | 0.01% | 677 |
|
|
2018
Q4 | – | Sell |
-10,276
| Closed | -$194K | – | 516 |
|
|
2018
Q3 | $194K | Sell |
10,276
-109,224
| -91% | -$2.06M | 0.01% | 435 |
|
|
2018
Q2 | $2.34M | Sell |
119,500
-29,100
| -20% | -$569K | 0.09% | 241 |
|
|
2018
Q1 | $2.79M | Sell |
148,600
-25,800
| -15% | -$485K | 0.09% | 231 |
|
|
2017
Q4 | $2.9M | Buy |
174,400
+111,113
| +176% | +$1.84M | 0.08% | 253 |
|
|
2017
Q3 | $1.3M | Buy |
+63,287
| New | +$1.3M | 0.04% | 328 |
|